ESPR — Esperion Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Esperion Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	201	305	259	167	82.2
Net Total Accounts Receivable
Net Total Receivables	—	—	22.9	33.7	48.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	212	346	329	247	201
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.68	7.31	2.56	1.2	4.67
Net Intangible Assets
Other Long Term Assets
Total Assets	214	353	382	248	206
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	66.1	94.1	73.4	92.3	156
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	194	449	579	572	661
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	19.9	-96.1	-197	-324	-455
Total Liabilities & Shareholders' Equity	214	353	382	248	206
Total Common Shares Outstanding